Skip to main content
Log in

ASO Visual Abstract: External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander C. J. van Akkooi MD, PhD.

Ethics declarations

Disclosures

Jonathan S. Zager reports grants from Amgen, Delcath Systems, Philogen, and Provectus; grants and personal fees from Castle Biosciences and Novartis; and personal fees from Pfizer, Merck, and Sun Pharma. Alexander van Akkooi reports advisory board and consultancy honoraria (all paid to institute and unrelated to current work) from Amgen, Bristol- Myers Squibb, Novartis; 4SC, Merck–Pfizer, MSD–Merck, Sanofi, and Sirius medical. The remaining authors made no disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stahlie, E.H.A., Carr, M.J., Zager, J.S. et al. ASO Visual Abstract: External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort. Ann Surg Oncol 29, 1647–1648 (2022). https://doi.org/10.1245/s10434-021-11143-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11143-2

Navigation